Interruption of antiretroviral therapy to augment immune control of chronic HIV-1 infection: Risk without reward
AUTOR(ES)
Abbas, Ume L.
FONTE
The National Academy of Sciences
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=129679Documentos Relacionados
- Randomized, Controlled Trial of Therapy Interruption in Chronic HIV-1 Infection
- Diagnosis, antiretroviral therapy, and emergence of resistance to antiretroviral agents in HIV-2 infection: a review
- Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes
- Early Therapy of Vertical Human Immunodeficiency Virus Type 1 (HIV-1) Infection: Control of Viral Replication and Absence of Persistent HIV-1-Specific Immune Responses
- Persistent HIV-1 infection of natural killer cells in patients receiving highly active antiretroviral therapy